NCT07300592 Development of a Static Balance Assessment Tool for High-Functioning Older Adults (KSVGH25-CT3-09)
| NCT ID | NCT07300592 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jia-Ling Hong |
| Condition | Balance Assessment |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-08-10 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-08-10 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This single-center interventional study aims to develop and validate a static balance assessment tool tailored for high-functioning older adults. Participants aged 65 years or older, who achieve a perfect score on the Short Physical Performance Battery and can maintain an open-eyes single-leg stance for at least 10 seconds, will be recruited. The assessment includes body composition measurement, open-eyes/closed-eyes single-leg stance, and the Balance Error Scoring System under firm and foam surface conditions. Each participant will undergo two testing sessions, 5-7 days apart, with both on-site and video-based scoring to determine test-retest reliability. The expected outcome is the development of an accurate and highly applicable static balance measurement tool to support healthy aging and fall prevention in community and long-term care settings.
Eligibility Criteria
Inclusion Criteria: * Age 60 to 85 years * Able to walk independently without assistive devices * No self-reported balance disorders or history of recurrent falls in the past 6 months * Cognitively intact (Mini-Mental State Examination score ≥ 24) * Willing and able to provide informed consent Exclusion Criteria: * Diagnosed neurological disorders affecting balance (e.g., Parkinson's disease, stroke with residual deficits) * Diagnosed neurological disorders affecting balance (e.g., Parkinson's disease, stroke with residual deficits) * Severe visual or vestibular impairment uncorrected by aids * Lower limb musculoskeletal disorders that limit mobility * Current participation in other interventional clinical trials * Unstable cardiovascular conditions (e.g., uncontrolled hypertension, recent myocardial infarction) * Severe visual or vestibular impairment uncorrected by aids * Lower limb musculoskeletal disorders that limit mobility * Current participation in other interventional clinical trials * Unstable cardiovascular conditions (e.g., uncontrolled hypertension, recent myocardial infarction)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07300592 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 80 Years, studying Balance Assessment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07300592 currently recruiting?
Yes, NCT07300592 is actively recruiting participants. Contact the research team at daben610357@gmail.com for enrollment information.
Where is the NCT07300592 trial being conducted?
This trial is being conducted at Kaohsiung City, Taiwan.
Who is sponsoring the NCT07300592 clinical trial?
NCT07300592 is sponsored by Jia-Ling Hong. The trial plans to enroll 50 participants.